Abstract
The management of Dysautonomia following severe traumatic brain injury (TBI) remains problematic, primarily due to an inadequate understanding of the pathophysiology of the condition. While the original theories inferred an epileptogenic source, there is greater support for disconnection theories in the literature. Disconnection theories suggest that Dysautonomia follows the release of one or more excitatory centres from higher centre control. Conventional disconnection theories suggest excitatory centre/s located in the upper brainstem and diencephalon drive paroxysms. Another disconnection theory, the Excitatory:Inhibitory Ratio (EIR) Model, suggests the causative brainstem/diencephalic centres are inhibitory in nature, with damage releasing excitatory spinal cord processes. Review of the available data suggests that Dysautonomia follows structural and/or functional (for example raised intracerebral pressure or neurotransmitter blockade) abnormalities, with the tendency to develop Dysautonomic paroxysms being more closely associated with mesencephalic rather than diencephalic damage. Many reports suggest that paroxysmal episodes can be triggered by environmental events and minimised by various but predictable neurotransmitter effects. This article presents a critical review of the competing theories against the available observational, clinical and neurotransmitter evidence. Following this process, it is suggested that the EIR Model more readily explains pathophysiological and treatment data compared to conventional disconnection models. In particular, the EIR Model provides an explanatory model that encompasses other acute autonomic emergency syndromes, accommodates ‘triggering’ of paroxysms and provides a rationale for all known medication effects.
Similar content being viewed by others
References
Baguley IJ, Nicholls JL, Felmingham KL, Crooks J, Gurka JA, Wade LD. Dysautonomia after traumatic brain injury: a forgotten syndrome? J Neurol Neurosurg Psychiatr 1999;67(1):39–43.
Baguley IJ. The excitatory:inhibitory model (EIR model): an integrative explanation of acute autonomic overactivity syndromes. Med Hypotheses 2007. doi: 10.1016/j.mehy.2007.04.037
Scott JS, Ockey RR, Holmes GE, Varghese G. Autonomic dysfunction associated with locked-in syndrome in a child. Am J Phys Med Rehabil 1997;76(3):200–3.
Lemke DM. Riding out the storm: sympathetic storming after traumatic brain injury. J Neurosci Nurs 2004;36(1):4–9.
Kishner S, Augustin J. Post head injury autonomic complications. Last updated 2006 October 4. Available from: http://www.emedicine.com/pmr/topic108.htm.
Penfield W. Diencephalic autonomic epilepsy. Arch Neurol Psychiatry 1929;22:358–74.
Carmel PW. Vegetative dysfunctions of the hypothalamus. Acta Neurochirurgica 1985;75(1–4):113–21.
Rossitch E, Bullard DE. The autonomic dysfunction syndrome: aetiology and treatment. Br J Neurosurg 1988;2:471–8.
Pranzatelli MR, Pavlakis SG, Gould RG, De Vivo DC. Hypothalamic-midbrain dysregulation syndrome: hypertension, hyperthermia, hyperventilation, and decerebration. J Child Neurol 1991;6:115–22.
Sneed RC. Hyperpyrexia associated with sustained muscle contractions: an alternative diagnosis to central fever. Arch Phys Med Rehabil 1995;76(1):101–3.
Boeve BF, Wijdicks EF, Benarroch EE, Schmidt KD. Paroxysmal sympathetic storms (“diencephalic seizures”) after severe diffuse axonal head injury. Mayo Clin Proc 1998;73(2):148–52.
Do D, Sheen VL, Broomfield E. Treatment of paroxysmal sympathetic storm with labetalol. J Neurol Neurosurg Psychiatr 2000;69(6):832–33.
Thorley RR, Wertsch JJ, Klingbeil GE. Acute hypothalamic instability in traumatic brain injury: a case report. Arch Phys Med Rehabil 2001;82(2):246–9.
Bhigjee AI, Ames FR, Rutherford GS. Adult aqueduct stenosis and diencephalic epilepsy. A case report. J Neurol Sci 1985;71(1):77–89.
Baguley IJ, Heriseanu RE, Gurka JA, Nordenbo A, Cameron ID. Gabapentin in the management of Dysautonomia following severe traumatic brain injury: a case series. J Neurol Neurosurg Psychiatr 2007;78(5):539–41.
Metz SA, Halter JB, Porte D Jr, Robertson RP. Autonomic epilepsy: clonidine blockade of paroxysmal catecholamine release and flushing. Anns Int Med 1978;88(2):89–193.
Bernath O. Treatment of paroxysmal sympathetic storm with labetalol. J Neurol Neurosurg Psychiatr 2001;70(6):818–9.
Hortnagl H, Hammerle AF, Hackl JM, Brucke T, Rumpl E, Hortnagl H. The activity of the sympathetic nervous system following severe head injury. Intensive Care Med 1980;6(3):169–77.
Klug N, Hoffman O, Zierski J, Buss K, Laun A, Agnoli AL. Decerebrate rigidity and vegetative signs in the acute midbrain syndrome with special regard to motor activity and intracranial pressure. Acta Neurochir 1984;72:219–33.
Sandel ME, Abrams PL, Horn LJ. Hypertension after brain injury: Case report. Arch Phys Med Rehabil 1986;67:469–72.
Bullard DE. Diencephalic seizures: responsiveness to bromocriptine and morphine. Ann Neurol 1987;21(6):609–11.
Hackl JM, Gottardis M, Wieser C, et al. Endocrine abnormalities in severe traumatic brain injury—a cue to prognosis in severe craniocerebral trauma? Intensive Care Med 1991;17(1):25–9.
Silver JK, Lux WE. Early onset dystonia following traumatic brain injury. Arch Phys Med Rehabil 1994;75(8):885–8.
Baguley IJ, Heriseanu RE, Felmingham KL, Cameron ID. Dysautonomia and heart rate variability following severe traumatic brain injury. Brain Inj 2006;20(4):437–44.
Blackman JA, Patrick PD, Buck ML, Rust RS Jr. Paroxysmal autonomic instability with dystonia after brain injury. Arch Neurol 2004;61(3):321–28.
Meythaler JM, Stinson AM. Fever of central origin in traumatic brain injury controlled with propranolol. Arch Phys Med Rehabil 1994;75(7):816–8.
Gennarelli TA. Mechanisms and pathophysiology of cerebral concussion. J Head Trauma Rehabil 1986;1(2):23–9.
Isbister GK, Buckley NA. The pathophysiology of serotonin toxicity in animals and humans: implications for diagnosis and treatment. Clin Neuropharmacol 2005;28(5):205–14.
Kipps CM, Fung VS, Grattan-Smith P, de Moore GM, Morris JG. Movement disorder emergencies.[see comment]. Mov Disord 2005;20(3):322–34.
Mohammed I, Hussain A. Intrathecal baclofen withdrawal syndrome—a life-threatening complication of baclofen pump: a case report. BMC Clin Pharmacol 2004;4:6.
McCarthy EJ. Malignant hyperthermia: pathophysiology, clinical presentation, and treatment. AACN Clin Issue 2004;15(2):231–7.
Cervero F, Laird JM. Mechanisms of touch-evoked pain (allodynia): a new model. Pain 1996;68(1):13–23.
Strich SJ. Diffuse degeneration of the cerebral white matter in severe dementia following head injury. J Neurol Neurosurg Psychiatr 1956;19:163–85.
Cuny E, Richer E, Castel JP. Dysautonomia syndrome in the acute recovery phase after traumatic brain injury: relief with intrathecal Baclofen therapy. Brain Inj 2001;15(10):917–25.
Meythaler JM, Peduzzi JD, Eleftheriou E, Novack TA. Current concepts: diffuse axonal injury-associated traumatic brain injury. Arch Phys Med Rehabil 2001;82(10):1461–71.
Fernandez-Ortega JF, Prieto-Palomino MA, Munoz-Lopez A, Lebron-Gallardo M, Cabrera-Ortiz H, Quesada-Garcia G. Prognostic influence and computed tomography findings in dysautonomic crises after traumatic brain injury. J Trauma-Injury Infect Crit Care 2006;61(5):1129–33.
Mazey RM, Kotchen TA, Ernst CB. A syndrome resembling pheochromocytoma following a stroke. Report of a case. JAMA 1974;230(4):575–7.
Becker R, Benes L, Sure U, Hellwig D, Bertalanffy H. Intrathecal baclofen alleviates autonomic dysfunction in severe brain injury. J Clin Neurosci 2000;7(4):316–9.
Evans CH, Westfall V, Atuk NO. Astrocytoma mimicking the features of pheochromocytoma. N Engl J Med 1972;286(26):1397–9.
Soloman GE. Diencephalic autonomic epilepsy caused by a neoplasm. J Pediatrics 1973;83:277–80.
Goh KYC, Conway EJ, DaRosso RC, Muszynski CA, Epstein FJ. Sympathetic storms in a child with midbrain glioma: a variant of diencephalic seizures. Pediatr Neurol 1999;21(4):742–4.
Talman WT, Florek G, Bullard DE. A hyperthermic syndrome in two subjects with acute hydrocephalus. Arch Neurol 1988;45(9):1037–40.
Lu CS, Ryu SJ. Neuroleptic malignant-like syndrome associated with acute hydrocephalus. Mov Disord 1991;6(4):381–3.
Baguley IJ. Nomenclature of “paroxysmal sympathetic storms”. Mayo Clin Proc 1999;74(1):105.
Diesing TS, Wijdicks EF. Arc de Cercle and Dysautonomia from anoxic injury. Mov Disord 2006;21(6):868–9.
Howie MB, Black HA, Zvara D, McSweeney TD, Martin DJ, Coffman JA. Esmolol reduces autonomic hypersensitivity and length of seizures induced by electroconvulsive therapy. Anesth Analg 1990;71:384–8.
Clifton GL, Robertson CS, Kyper K, Taylor AA, Dhekne RD, Grossman RG. Cardiovascular response to severe head injury. J Neurosurg 1983;59(3):447–54.
Russo RN, O’Flaherty S. Bromocriptine for the management of autonomic dysfunction after severe traumatic brain injury. J Paediat Child Health 2000;36(3):283–5.
Baguley IJ, Cameron ID, Green AM, Slewa-Younan S, Marosszeky JE, Gurka JA. Pharmacological management of Dysautonomia following traumatic brain injury. Brain Inj 2004;18(5):409–17.
Lemke DM. Sympathetic storming after severe traumatic brain injury. Crit Care Nurse 2007;27(1):30–7.
Payen D, Quintin L, Plaisance P, Chiron B, Lhoste F. Head injury: clonidine decreases plasma catecholamines. Crit Care Med 1990;18(4):392–5.
Baguley IJ, Heriseanu RE, Slewa-Younan S. Clonidine in the management of Dysautonomia following severe traumatic brain injury. Neurorehabil Neural Repair 2006;20(1):98–9.
Gordon WA, Zafonte R, Cicerone K, et al. Traumatic brain injury rehabilitation: state of the science. Am J Phys Med Rehabil 2006;85(4):343–82.
Wortsman J, Burns G, Van Beek AL, Couch J. Hyperadrenergic state after trauma to the neuroaxis. J Am Med Assoc 1980;243(14):1459–60.
Feibel JH, Baldwin CA, Joynt RJ. Catecholamine-associated refractory hypertension following acute intracranial hemorrhage: control with propranolol. Ann Neurol 1981;9(4):340–3.
Robertson CS, Clifton GL, Taylor AA, Grossman RG. Treatment of hypertension associated with head injury. J Neurosurg 1983;59:455–60.
Chiolero RL, Breitenstein E, Thorin D, et al. Effects of propranolol on resting metabolic rate after severe head injury. Crit Care Med 1989;17(4):328–34.
Ener RA, Meglathery SB, Van Decker WA, Gallagher RM. Serotonin syndrome and other serotonergic disorders. Pain Med 2003;4(1):63–74.
Ivanhoe CB, Tilton AH, Francisco GE. Intrathecal baclofen therapy for spastic hypertonia. Phys Med Rehabili Clin of N Am 2001;12(4):923–38.
Baguley IJ, Bailey KM, Slewa-Younan S. Prolonged anti-spasticity effects of bolus intrathecal baclofen. Brain Inj 2005;19(7):545–8.
Green LB, Nelson VS. Death after acute withdrawal of intrathecal baclofen: case report and literature review. Arch Phys Med Rehabil 1999;80(12):1600–4.
Cheng JK, Chiou LC. Mechanisms of the antinociceptive action of gabapentin. J Pharmacol Sci 2006;100(5):471–86.
Rose MA, Kam PC. Gabapentin: pharmacology and its use in pain management. Anaesthesia 2002;57(5):451–62.
Sutton KG, Martin DJ, Pinnock RD, Lee K, Scott RH. Gabapentin inhibits high-threshold calcium channel currents in cultured rat dorsal root ganglion neurons. Br J Pharmacol 2002;135(1):257–65.
Onofrj M, Thomas A. Acute akinesia in Parkinson disease. Neurology 2005;64(7):1162–9.
Figa-Talamanca L, Gualandi C, Di Meo L, Di Battista G, Neri G, Lo RF. Hyperthermia after discontinuance of levodopa and bromocriptine therapy: impaired dopamine receptors a possible cause. Neurology 1985;35(2):258–61.
Meagher LJ, McKay D, Herkes GK, Needham M. Parkinsonism-hyperpyrexia syndrome: the role of electroconvulsive therapy. J Clin Neurosci 2006;13:857–9.
Vincent FM, Zimmerman JE, Van Haren J. Neuroleptic malignant syndrome complicating closed head injury. Neurosurgery 1986;18(2):190–3.
Perez Vela JL, Sanchez Casado M, Sanchez Izquierdo Riera JA, Ambros Checa A, Caballero Cubedo R, Alted Lopez E. Neuroleptic malignant syndrome in a patient with head injury. Intensive Care Med 1996;22(6):593–5.
Trasmonte J, Dayner J, Barron TF. Neuroleptic malignant syndrome in an adolescent head trauma patient. Clin Pediatr 1999;38(10):611–3.
Rothman RB, Baumann MH. Balance between dopamine and serotonin release modulates behavioral effects of amphetamine-type drugs. Ann N Y Acad Sci 2006;1074(8):245–60.
Acknowledgement
This work resulted, in part, from a project funded by the Motor Accidents Authority of New South Wales, Australia.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Baguley, I.J., Heriseanu, R.E., Cameron, I.D. et al. A Critical Review of the Pathophysiology of Dysautonomia Following Traumatic Brain Injury. Neurocrit Care 8, 293–300 (2008). https://doi.org/10.1007/s12028-007-9021-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12028-007-9021-3